Physician
Friedman, Rebecca
Friedman, Rebecca was paid $1.01M by Medicaid between Jan 2018 and May 2023, across 29 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 41% of everything it billed.
33Billing provider infoFRIEDMAN, REBECCA
JOHNSTON, RI 02919
JOHNSTON, RI 02919
33aNPI1639331424assigned 07/02/2008
33bProvider typePediatrics Physician
28Total paid$1.01M
24GClaims25,247
24DCodes billed29
24AFirst – last monthJan 2018 – May 2023
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#16 of 265
Median peer was paid$133K
This provider vs. median7.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,290 | $182K | |
| 2019 | 963 | $29K | |
| 2020 | 5,285 | $195K | |
| 2021 | 5,859 | $232K | |
| 2022 | 5,683 | $246K | |
| 2023 | 2,167 | $130K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 41% | 7,565 | 6,539 | $412K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 2,104 | 1,751 | $127K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 1,712 | 1,652 | $114K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.2% | 1,044 | 1,016 | $73K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.5% | 700 | 621 | $55K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.8% | 634 | 615 | $49K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4.8% | 2,701 | 2,582 | $49K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.5% | 4,087 | 3,913 | $35K |
| 87428 | 3.1% | 556 | 541 | $31K | |
| 99051 | 1.2% | 489 | 479 | $12K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 301 | 264 | $12K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 865 | 841 | $11K |
17 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 729 | $7K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 119 | $6K |
| 90473 | <1% | 407 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 133 | $4K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 29 | $3K |
| 99460 | <1% | 66 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 279 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 19 | $2K |
| 0072A | <1% | 29 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 45 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 31 | $466.23 |
| 0051A | <1% | 12 | $429.39 | |
| 88720 | <1% | 17 | $63.89 | |
| 90686 | <1% | 411 | $19.30 | |
| 90670 | <1% | 104 | $4.95 | |
| 90723 | <1% | 47 | $2.30 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $1.82 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.